Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmelo Rizzari

Showing results (21-30 of 149) with videos related to

Pageof 15
Sort By:
Archives of Disease in Childhood|April 16, 2021
Recommendations by the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) Working Group on preparedness of clinical trials about paediatric medicines processAngeliki Siapkara, Claudio Fracasso, Gunter F Egger, et al.
Bone Marrow Transplantation|April 22, 2020
Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote paratiAdriana Balduzzi, Erica Brivio, Attilio Rovelli, et al.
British Journal of Haematology|December 21, 2002
FLT3 internal tandem duplication in childhood acute myeloid leukaemia: association with hyperleucocytosis in acute promyelocytic leukaemiaPaolo Arrigoni, Chiara Beretta, Daniela Silvestri, et al.
ESMO Open|September 24, 2020
Increasing completion of asparaginase treatment in childhood acute lymphoblastic leukaemia (ALL): summary of an expert panel discussionAndré Baruchel, Patrick Brown, Carmelo Rizzari, et al.
Mediterranean Journal of Hematology and Infectious Diseases|April 21, 2022
Challenging Management of Severe Differentiation Syndrome in Pediatric Acute Promyelocytic Leukemia Treated with ATRA/ATOAlessandro Molinaro, Daniela Zanta, Maria Luisa Moleti, et al.
European Journal of Medical Genetics|November 6, 2016
Williams syndrome and mature B-Leukemia: A random association?Valentina Decimi, Grazia Fazio, Fabiola Dell'Acqua, et al.
European Journal of Drug Metabolism and Pharmacokinetics|December 8, 2021
Impact of Antibodies Against Polyethylene Glycol on the Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukaemia: A Population Pharmacokinetic ApproachChristian Siebel, Claudia Lanvers-Kaminsky, Julia Alten, et al.
Haematologica|January 26, 2006
A pharmacological study on pegylated asparaginase used in front-line treatment of children with acute lymphoblastic leukemiaCarmelo Rizzari, Marco Citterio, Massimo Zucchetti, et al.
Cancer Chemotherapy and Pharmacology|June 4, 2008
Pharmacokinetic profile of imatinib mesylate and N-desmethyl-imatinib (CGP 74588) in children with newly diagnosed Ph+ acute leukemiasElena Marangon, Marco Citterio, Federica Sala, et al.
Haematologica|September 5, 2024
Blinatumomab is associated with better post-transplant outcome than chemotherapy in children with high-risk, first-relapse B-cell acute lymphoblastic leukemia irrespective of the conditioning regimenChristina Peters, Angela Bruno, Carmelo Rizzari, et al.
Pageof 15

Showing results (21-30 of 149) with videos related to

Sort By:
Pageof 15
Archives of Disease in Childhood|April 16, 2021
Recommendations by the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) Working Group on preparedness of clinical trials about paediatric medicines processAngeliki Siapkara, Claudio Fracasso, Gunter F Egger, et al.
Bone Marrow Transplantation|April 22, 2020
Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote paratiAdriana Balduzzi, Erica Brivio, Attilio Rovelli, et al.
British Journal of Haematology|December 21, 2002
FLT3 internal tandem duplication in childhood acute myeloid leukaemia: association with hyperleucocytosis in acute promyelocytic leukaemiaPaolo Arrigoni, Chiara Beretta, Daniela Silvestri, et al.
ESMO Open|September 24, 2020
Increasing completion of asparaginase treatment in childhood acute lymphoblastic leukaemia (ALL): summary of an expert panel discussionAndré Baruchel, Patrick Brown, Carmelo Rizzari, et al.
Mediterranean Journal of Hematology and Infectious Diseases|April 21, 2022
Challenging Management of Severe Differentiation Syndrome in Pediatric Acute Promyelocytic Leukemia Treated with ATRA/ATOAlessandro Molinaro, Daniela Zanta, Maria Luisa Moleti, et al.
European Journal of Medical Genetics|November 6, 2016
Williams syndrome and mature B-Leukemia: A random association?Valentina Decimi, Grazia Fazio, Fabiola Dell'Acqua, et al.
European Journal of Drug Metabolism and Pharmacokinetics|December 8, 2021
Impact of Antibodies Against Polyethylene Glycol on the Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukaemia: A Population Pharmacokinetic ApproachChristian Siebel, Claudia Lanvers-Kaminsky, Julia Alten, et al.
Haematologica|January 26, 2006
A pharmacological study on pegylated asparaginase used in front-line treatment of children with acute lymphoblastic leukemiaCarmelo Rizzari, Marco Citterio, Massimo Zucchetti, et al.
Cancer Chemotherapy and Pharmacology|June 4, 2008
Pharmacokinetic profile of imatinib mesylate and N-desmethyl-imatinib (CGP 74588) in children with newly diagnosed Ph+ acute leukemiasElena Marangon, Marco Citterio, Federica Sala, et al.
Haematologica|September 5, 2024
Blinatumomab is associated with better post-transplant outcome than chemotherapy in children with high-risk, first-relapse B-cell acute lymphoblastic leukemia irrespective of the conditioning regimenChristina Peters, Angela Bruno, Carmelo Rizzari, et al.
Pageof 15